Pulmonary hypertension is a substantial global health issue. All age groups are affected with
rapidly growing importance in elderly people, particularly in countries with ageing …

Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a
chronic and progressive disorder characterised by angioproliferative vasculopathy in the …

Abstract The Rotterdam Study is an ongoing prospective cohort study that started in 1990 in
the city of Rotterdam, The Netherlands. The study aims to unravel etiology, preclinical …

Background: Coronavirus (Covid-19) infection represents a serious medical condition, often
associated with cardiovascular complications, pulmonary hypertension (PH), and right …

Pulmonary hypertension is an enigmatic, deleterious disease driven by multiple
heterogeneous causes with a burgeoning proportion of older patients with complex, chronic …

Pulmonary hypertension (PH) is caused by a range of conditions and is important to
recognize as it is associated with increased mortality. Pulmonary arterial hypertension refers …

Background Currently an echocardiographic threshold for the tricuspid regurgitation
gradient (TRG) of> 31 mmHg is recommended for screening for pulmonary hypertension …

Dyspnea is a frequent, devastating, and poorly understood symptom of advanced lung
cancer. In our cohort, among 519 patients who underwent a computed tomography scan for …

Pulmonary hypertension is associated with increased morbidity and mortality, and growing
evidence suggests that even mild elevations in pulmonary artery pressure estimated with …

Background In the early literature, unintentional vitamin C deficiency in humans was
associated with heart failure. Experimental vitamin C deficiency in guinea pigs caused …